Goal and Learning Outcomes

The goal of this course is to provide nurses in acute care with knowledge of myocardial infarction.
 
After taking this course, you should be able to:
  • Differentiate the signs and symptoms of myocardial infarction for men and women.
  • Describe two diagnostic studies for myocardial infarction.
  • Discuss the emergency management of myocardial infarction.
  • Identify nursing assessments, interventions, and monitoring for those with myocardial infarction.

 
 
Effective 8/1/2014, the Florida Board of Nursing will not accept contact hours offered in tenth hour increments (example: 1.6 contact hours). Course contact hours will be rounded down to the nearest half hour (example: 1.6 contact hours becomes 1.5 contact hours, 1.4 contact hours becomes 1.0 contact hours). This course will be reported to CE Broker for FL RNs, LPNs, ARNPs, and CNSs as 1.5 hours.

Course Authors

Accreditation Information

NURSES

In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Provider approved by the California Board of Registered Nursing, CEP#13791

 

CEBroker

Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, New Mexico Board Of Nursing, South Carolina Board Of Nursing and  West Virginia Board Of Examiners For Registered Professional Nurses

 

Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.

 

Disclosures

None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.